George Murphy
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,900 | 184 | 93.8% |
| Education | $326.30 | 7 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,280 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $564.96 | 25 | $0 (2024) |
| PFIZER INC. | $462.56 | 25 | $0 (2024) |
| Amgen Inc. | $388.89 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $378.49 | 18 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $298.38 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $295.84 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $248.61 | 12 | $0 (2024) |
| Boston Scientific Corporation | $226.57 | 12 | $0 (2024) |
| CMP Pharma, Inc. | $207.07 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,291 | 47 | AstraZeneca Pharmaceuticals LP ($333.17) |
| 2023 | $1,599 | 52 | AstraZeneca Pharmaceuticals LP ($448.43) |
| 2022 | $1,764 | 70 | AstraZeneca Pharmaceuticals LP ($373.56) |
| 2021 | $572.38 | 22 | CMP Pharma, Inc. ($149.18) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Transcatheter Heart Valves | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $86.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.05 | General |
| 07/26/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: WATCHMAN_IC | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/10/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.36 | General |
| 07/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 731 | 1,055 | $249,867 | $65,376 |
| 2022 | 7 | 792 | 1,218 | $255,910 | $74,251 |
| 2021 | 5 | 437 | 489 | $115,200 | $34,354 |
| 2020 | 1 | 15 | 15 | $19,020 | $1,741 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 363 | 608 | $152,100 | $43,671 | 28.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 140 | $41,160 | $10,582 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 60 | $34,440 | $6,150 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 65 | $13,795 | $3,453 | 25.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 179 | 182 | $8,372 | $1,520 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 420 | 753 | $169,425 | $54,792 | 32.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 55 | 135 | $39,690 | $8,938 | 22.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $20,664 | $4,468 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 22 | $7,700 | $2,301 | 29.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 230 | 241 | $11,086 | $1,953 | 17.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 15 | $4,545 | $1,020 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 16 | $2,800 | $778.86 | 27.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 309 | 352 | $79,199 | $29,538 | 37.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 14 | 14 | $17,752 | $1,612 | 9.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $4,200 | $1,433 | 34.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 92 | 100 | $4,600 | $945.81 | 20.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 11 | 11 | $9,449 | $824.60 | 8.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 15 | 15 | $19,020 | $1,741 | 9.2% |
About George Murphy
George Murphy is a Student in an Organized Health Care Education/Training Program healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2018. The National Provider Identifier (NPI) number assigned to this provider is 1831693795.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, George Murphy has received a total of $5,227 in payments from pharmaceutical and medical device companies, with $1,291 received in 2024. These payments were reported across 191 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,900).
As a Medicare-enrolled provider, Murphy has provided services to 1,975 Medicare beneficiaries, totaling 2,777 services with total Medicare billing of $175,721. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Portland, OR
- Active Since 03/23/2018
- Last Updated 02/18/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831693795
Products in Payments
- ELIQUIS (Drug) $685.24
- FARXIGA (Drug) $682.96
- Repatha (Biological) $388.89
- VERQUVO (Drug) $378.49
- BRILINTA (Drug) $289.80
- CAMZYOS (Drug) $257.03
- JARDIANCE (Drug) $248.61
- LOKELMA (Drug) $207.29
- Carospir (Drug) $188.73
- WATCHMAN Access System (Device) $181.97
- AMVUTTRA (Drug) $173.11
- LEQVIO (Drug) $168.48
- ENTRESTO (Drug) $127.36
- ONPATTRO (Drug) $125.27
- TRELEGY ELLIPTA (Drug) $116.92
- DUPIXENT (Biological) $104.67
- NEXLETOL (Drug) $100.83
- Kerendia (Drug) $94.59
- VYNDAQEL (Drug) $76.16
- Inpefa (Drug) $48.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Portland
Amanda Vansandt, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $280,593
Mathew Geltzeiler, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $186,613
Josha Woodward
Student in an Organized Health Care Education/Training Program — Payments: $99,642
Dr. Julie Graff, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $60,054
Trevor Crafts, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $50,126
Adel Kardosh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,266